The relationship between inflammation and arterial stiffness in patients with essential hypertension

International Journal of Cardiology

Volumn 112, Issue 1, 2006, Pages 46-51

  Kampus, Priit ^a   Muda, Piibe ^a   Kals, Jaak ^a   Ristimäe, Tiina ^a   Fischer, Krista ^a   Teesalu, Rein ^a   Zilmer, Mihkel ^a  

^a UNIVERSITY OF TARTU   (Estonia)

Author keywords

Arterial stiffness; Augmentation index; Hypertension; Inflammation

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; FIBRINOGEN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY HEIGHT; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ESSENTIAL HYPERTENSION; FEMALE; HEART RATE; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; MALE; MEAN ARTERIAL PRESSURE; MULTIPLE REGRESSION; PRIORITY JOURNAL; PULSE WAVE; REGRESSION ANALYSIS; RIGIDITY; RISK FACTOR; STATISTICAL SIGNIFICANCE;

EID: 33747376414     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2005.08.026     Document Type: Article

References (33)

1. van Popele N.M., Grobbee D.E., Bots M.L., et al. Association between arterial stiffness and atherosclerosis. Stroke 32 (2001) 454-460
2. Boutouyrie P., Tropeano A.I., Asmar R., et al. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension 39 (2002) 10-15
3. Glasser S.P., Arnett D.K., McVeigh G.E., et al. Vascular compliance and cardiovascular disease: a risk factor or a marker?. Am J Hypertens 10 (1997) 1175-1189
4. Laurent S., Boutouyrie P., Asmar R., et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 37 (2001) 1236-1241
5. Saito M., Ishimitsu T., Minami J., Ono H., Ohrui M., and Matsuoka H. Relations of plasma high-sensitivity C-reactive protein to traditional cardiovascular risk factors. Atherosclerosis 167 (2003) 73-79
6. Sung K.C., Suh J.Y., Kim B.S., et al. High sensitivity C-reactive protein as an independent risk factor for essential hypertension. Am J Hypertens 16 (2003) 429-433
7. Sesso H.D., Buring J.E., Rifai N., Blake G.J., Gaziano J.M., and Ridker P.M. C-reactive protein and the risk of developing hypertension. JAMA 290 (2003) 2945-2951
8. Abramson J.L., Weintraub W.S., and Vaccarino V. Association between pulse pressure and C-reactive protein among apparently healthy US adults. Hypertension 39 (2002) 197-202
9. Schillaci G., Pirro M., Gemelli F., et al. Increased C-reactive protein concentrations in never-treated hypertension: the role of systolic and pulse pressures. J Hypertens 21 (2003) 1841-1846
10. Kampus P., Kals J., Ristimäe T., Fischer K., Zilmer M., and Teesalu R. High-sensitivity C-reactive protein affects central haemodynamics and augmentation index in apparently healthy persons. J Hypertens 22 (2004) 1133-1139
11. Yasmin, McEniery C.M., Wallace S., Mackenzie I.S., Cockcroft J.R., and Wilkinson I.B. C-reactive protein is associated with arterial stiffness in apparently healthy individuals. Arterioscler Thromb Vasc Biol 24 (2004) 969-974
12. Wilkinson I.B., Fuchs S.A., Jansen I.M., et al. Reproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis. J Hypertens 16 (1998) 2079-2084
13. Pauca A.L., O'Rourke M.F., and Kon N.D. Prospective evaluation of a method for estimating ascending aortic pressure from the radial artery pressure waveform. Hypertension 38 (2001) 932-937
14. Chen C.H., Nevo E., Fetics B., et al. Estimation of central aortic pressure waveform by mathematical transformation of radial tonometry. Circulation 95 (1997) 1827-1836
15. London G., Guerin A., Pannier B., Marchais S., Benetos A., and Safar M. Increased systolic pressure in chronic uraemia: role of arterial wave reflections. Hypertension 20 (1992) 10-19
16. Wilkinson I.B., MacCallum H., Cockcroft J.R., and Webb D.J. Inhibition of basal nitric oxide synthesis increases aortic augmentation index and pulse wave velocity in vivo. Br J Clin Pharmacol 53 (2002) 189-192
17. Wilkinson I.B., MacCallum H., Hupperetz P.C., van Thoor C.J., Cockcroft J.R., and Webb D.J. Changes in the derived central pressure waveform and pulse pressure in response to angiotensin II and noradrenaline in man. J Physiol 530 (2001) 541-550
18. Kals J, Kampus P, Kals M, Pulges A, Teesalu R, Zilmer M. Effects of stimulation of nitric oxide synthesis on large artery stiffness in patients with peripheral arterial disease. Atherosclerosis 2005 Jul 26; (in press).
19. Shankar A., Klein B.E., and Klein R. Relationship between white blood cell count and incident hypertension. Am J Hypertens 17 (2004) 233-239
20. Fisher A.B., Chien S., Barakat A.I., and Nerem R.M. Endothelial cellular response to altered shear stress. Am J Physiol Lung Cell Mol Physiol 28 (2001) L529-L533
21. Venugopal S.K., Devaraj S., Yuhanna I., Shaul P., and Jialal I. Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells. Circulation 106 (2002) 1439-1441
22. Verma S., Li S.H., Badiwala M.V., et al. Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein. Circulation 105 (2002) 1890-1896
23. Wang C.H., Li S.H., Weisel R.D., et al. C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle. Circulation 107 (2003) 1783-1790
24. Ross R. Atherosclerosis: an inflammatory disease. N Eng J Med 340 (1999) 115-126
25. Booth A.D., Wallace S., McEniery C.M., et al. Inflammation and arterial stiffness in systemic vasculitis: a model of vascular inflammation. Arthritis Rheum 50 (2004) 581-588
26. Tomiyama H., Arai T., Koji Y., et al. The relationship between high-sensitive C-reactive protein and pulse wave velocity in healthy Japanese men. Atherosclerosis 174 (2004) 373-377
27. Mattace-Raso F.U., van der Cammen T.J., van der Meer I.M., et al. C-reactive protein and arterial stiffness in older adults: the Rotterdam Study. Atherosclerosis 176 (2004) 111-116
28. Lacy P.S., O'Brien D.G., Stanley A.G., Dewar M.M., Swales P.P., and Williams B. Increased pulse wave velocity is not associated with elevated augmentation index in patients with diabetes. J Hypertens 10 (2004) 1937-1944
29. Kelly R.P., Millasseau S.C., Ritter J.M., and Chowienczyk P.J. Vasoactive drugs influence aortic augmentation index independently of pulse-wave velocity in healthy men. Hypertension 37 (2001) 1429-1433
30. Wilhelmsen L., Svardsudd K., Korsan-Bengtsen K., Larsson B., Welin L., and Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 311 (1984) 501-505
31. Engstrom G., Lind P., Hedblad B., Stavenow L., Janzon L., and Lindgarde F. Long-term effects of inflammation-sensitive plasma proteins and systolic blood pressure on incidence of stroke. Stroke 33 (2002) 2744-2749
32. De Bacquer D., De Backer G., Braeckman L., and Baele G. Intra-individual variability of fibrinogen levels. J Clin Epidemiol 50 (1997) 393-399
33. Stec J.J., Silbershatz H., Tofler G.H., et al. Association of fibrinogen with cardiovascular risk factors and cardiovascular disease in the Framingham Offspring Population. Circulation 102 (2000) 1634-1638